Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
831.3 USD | +1.33% | +2.95% | +42.60% |
Jun. 03 | Eli Lilly: encouraging data for olomorasib | CF |
Jun. 03 | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B | |
+1.81% | 166B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and : , Incyte Say Baricitinib Meets Phase 3 Efficacy Endpoint in Treating Baldness